Abstract
Non-pharmaceutical interventions (NPIs), including measures such as lockdowns, travel limitations, and social distancing mandates, play a critical role in shaping human mobility, which subsequently influences the spread of infectious diseases. Using COVID-19 as a case study, this research examines the relationship between restrictions, mobility patterns, and the disease’s effective reproduction number (Rt) across 13 European countries. Employing clustering techniques, we uncover distinct national patterns, highlighting differences in social compliance between Northern and Southern Europe. While restrictions strongly correlate with mobility reductions, the relationship between mobility and Rt is more nuanced, driven primarily by the nature of social interactions rather than mere compliance. Additionally, employing XGBoost regression models, we demonstrate that missing mobility data can be accurately inferred from restrictions, and missing infection rates can be predicted from mobility data. These findings provide valuable insights for tailoring public health strategies in future crisis and refining analytical approaches.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from TED2021-131264B-I00 (SocialProbing) funded by MCIN/AEI/10.13039/501100011033 and the European Union "NextGenerationEU"/PRTR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Board (IRB) of IMDEA Networks Institute gave ethical approval for this work on 2021/07/05. IMDEA Networks has signed Data Use Agreements with Facebook, Carnegie Mellon University (CMU) and the University of Maryland (UMD) to access their data, specifically UMD project 1587016-3 entitled C-SPEC: Symptom Survey: COVID-19 and CMU project STUDY2020\_00000162 entitled ILI Community-Surveillance Study. The data used in this study was collected by the University of Maryland through The University of Maryland Social Data Science Center Global COVID-19 Trends and Impact Survey in partnership with Facebook. Informed consent has been obtained from all participants in this survey by this institution. All the methods in this study have been carried out in accordance with relevant of ethics and privacy guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.